Atlas Trials

Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer

Clinical trial NCT02177838 · TERMINATED

Trial details

NCT number
NCT02177838
Sponsor
Rutgers, The State University of New Jersey
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the OropharynxStage III Verrucous Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the HypopharynxStage IVA Squamous Cell Carcinoma of the LarynxStage IVA Squamous Cell Carcinoma of the OropharynxStage IVA Verrucous Carcinoma of the LarynxStage IVB Squamous Cell Carcinoma of the LarynxStage IVB Squamous Cell Carcinoma of the OropharynxStage IVB Verrucous Carcinoma of the LarynxTongue Cancer
Start date
2015-03-25
Primary completion
2019-08-22
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.